Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prehypertension.

William J Elliott1, Henry R Black

  • 1Department of Preventive Medicine, RUSH Medical College, RUSH University Medical Center, Chicago, IL 60612, USA. welliott@rush.edu

Nature Clinical Practice. Cardiovascular Medicine
|September 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins.

Circulation·2019
Same author

Reducing the Expenditures and Workload Associated With VA Partial-Fill Prescription Processing.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2019
Same author

The costs of treating hypertension.

Postgraduate medicine·2017
Same author

Cardiovascular risk factors.

Postgraduate medicine·2017
Same author

Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.

Expert opinion on drug safety·2017
Same author

Prehypertension-What Is It and Should It Be Treated?

Journal of clinical hypertension (Greenwich, Conn.)·2017

Prehypertension, elevated blood pressure, is common and raises cardiovascular risks. Lifestyle changes may help, but drug treatment is reserved for specific high-risk groups pending further research.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Prehypertension (blood pressure 120-139/80-89 mmHg) is a widespread condition, particularly among obese youth.
  • It frequently coexists with other cardiovascular risk factors and independently elevates the risk of developing hypertension and experiencing cardiovascular events.
  • Current lifestyle modifications offer unreliable reduction of prehypertension in the general population.

Purpose of the Study:

  • To review recent data on the epidemiology of prehypertension.
  • To summarize the associated risks of prehypertension.
  • To discuss potential treatment strategies for prehypertension.

Main Methods:

  • Literature review of recently published data.
  • Synthesis of epidemiological findings.

Related Experiment Videos

  • Analysis of cardiovascular risks and treatment options.

    • Main Results:

    • Prehypertension is a significant public health issue with increasing prevalence.
    • It is linked to heightened risks of hypertension and cardiovascular events.
    • Drug therapy is generally not recommended except for specific comorbidities due to cost and unproven long-term benefits.

    Conclusions:

    • Further research is needed to identify individuals who would benefit from treatment.
    • Management strategies for prehypertension require careful consideration of risks and benefits.
    • Addressing prehypertension is crucial for mitigating future cardiovascular disease burden.